Blood Coagulation & Fibrinolysis

Article	Citations
The role of thrombin in haemostasis	47
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis	17
Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case	16
Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis	16
Coronavirus disease 2019 and coagulopathy: other prothrombotic coagulation factors	16
Blood biocompatibility enhancement of biomaterials by heparin immobilization: a review	15
Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma	13
The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study	13
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?	13
The physiology of hemostasis	13
Evaluating the potential benefits of the extravascular pool of factor IX	11
Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU	11
Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit	11
A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients	10
Coronavirus disease 2019 in patients with chronic immune thrombocytopenia on thrombopoietin receptor agonists: new perspectives and old challenges	10
ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand	9
First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpura	9
Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings	9
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review	9
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism	9
Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States	9
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice	8
Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls	8
Thrombin generation assay: the present and the future	7
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening	7

Reversal of factor Xa inhibitors associated intracranial haemorrhage at a tertiary medical centre	7
Application of microfluidic chip technology to study the inhibitory effect of tetramethylpyrazine on platelet aggregation, activation, and phosphatidylserine exposure mediated by pathological high she	7
Viscoelastic hemostasis assays in septic, critically ill coronavirus disease 2019 patients: a practical guide for clinicians	7
Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection	7
Derangement of the coagulation process using subclinical markers and viscoelastic measurements in critically ill patients with coronavirus disease 2019 pneumonia and non-coronavirus disease 2019 pneum	7
Human coagulation factor IX: a systematic review of its characteristics	7
Immune thrombocytopenia: options and new perspectives	7
Platelet hyperaggregability and venous thrombosis risk: results from the RETROVE project	7
Use of thrombolytic agents to treat neonatal thrombosis in clinical practice	6
Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series	6
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies	6
Screening hemostatic defects in Saudi University students with unexplained menorrhagia: a diagnosis, which could be missed	6
HbA1c/C-peptide ratio is associated with angiographic thrombus burden and short-term mortality in patients presenting with ST-elevation myocardial infarction	6
Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo	6
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?	6
A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal	6
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study	6
Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019: a meta-analysis	6
Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, co	6
Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study	5
Age, sex and racial differences in fibrin formation and fibrinolysis within the healthy population	5
Harmonizing factor assay-related testing performed in a large laboratory network	5
In-vitro thromboelastographic characterization of reconstituted whole blood utilizing cryopreserved platelets	5
Assessment of endothelial progenitor cells, VEGF-A and SDF-1α in Hodgkin's lymphoma	5
Psychological complications among patients with congenital bleeding disorders	5
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy	5
A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism	5
Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis	5
Clinical characteristics and outcomes of patients with isolated pulmonary embolism	5
Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer	4
Evaluation of 4Ts score inter-rater agreement in patients undergoing evaluation for heparin-induced thrombocytopenia	4
General concepts on hemophilia A and on women carrying the disease	4
Hemophilia carriers: quality of life and management at different life stages	4
Homozygous methylentetrahydrofolate reductase C667T genotype anticipates age at venous thromboembolism by one decade	4
Type II antithrombin deficiency caused by a novel missense mutation (p.Leu417Gln) in a Chinese family	4
Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia	4
Venous thromboembolism and acute myeloid leukemia: risk factors and mortality in elderly white, black and Asian patients	4
Microparticles: a link to increased thrombin generation	4
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant	4
Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort	4
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination	4
Apoptosis in platelets from adult patients with chronic idiopathic thrombocytopenic purpura	4
A challenging case of heparin-induced skin necrosis without thrombocytopenia	4
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event	4
Mannose-binding lectin-associated serine protease-1 cleaves plasminogen and plasma fibronectin: prefers plasminogen over known fibrinogen substrate	4
Interference of icterus on plasma D-dimer levels measured using immunoturbidimetric assays	4
Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019	3
Foundations of hemophilia and epidemiology	3
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier	3
Microkinetic coagulation assays for human and zebrafish plasma	3

A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream	3
Cost-effectiveness of thrombotic thrombocytopenic purpura diagnosis: a retrospective analysis in the University Hospital Center of Lyon (France)	3
A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene	3
Ruthenium-based antivenom attenuates Crotalus atrox venom mediated coagulopathy in rabbits	3
Very low-dose recombinant Factor VIIa administration for cardiac surgical bleeding reduces red blood cell transfusions and renal risk: a matched cohort study	3
Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia	3
Soluble thrombomodulin and cardiovascular disease risk factors in Japanese children	3
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome	3
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock	3
New developments in the diagnosis of primary immune thrombocytopenia	3
Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?	3
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms	3
Spinal epidural hematoma in a child with hemophilia A with high titer inhibitors and follow-up with prophylactic emicizumab: case report and literature review	3
Cangrelor for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia: it is not so easy	3
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation	3
The effect of tranexamic acid on myocardial injury in cardiac surgical patients: a systematic review and meta-analysis	3
The evaluation of reactive oxygen species generation and free mitochondrial DNA in platelet concentrates during 5 days of storage	3
The impact of atorvastatin on dabigatran plasma levels in patients with atrial fibrillation	3
Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial	3
Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report	3
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment	2
Relationship between oxidant-antioxidant status and hypercoagulobility indices in children with iron deficiency anaemia	2
Assessment of clinical characteristics and treatment outcomes of pediatric patients with intracardiac thrombosis: a single-center experience	2
Prolonged prothrombin time does not correlate with clinical bleeding symptoms in newly diagnosed paediatric leukaemia patients	2
A multicentre real-world data study to assess the bleeding rate and management of patients with haemophilia A and factor VIII inhibitors in Argentina	2
Risk factors for recurrent venous thromboembolism: a real-world analysis	2
Association of hemostasis and inflammation biomarkers with outcomes in acute coronary syndromes	2
Prevalence and risk factors for pulmonary embolism in children with sickle cell disease: an institutional retrospective cohort study	2
Evaluation of ISTH-BAT as a predictor for factor deficiency in haemophilia carriers: a single-centre experience	2
Postacute elevation of D-dimer levels in severe acute respiratory syndrome coronavirus 2-positive nonhospitalized patients with mild symptoms	2
Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum period	2
Prenatal diagnostic techniques and IVF in patients with coagulopathies	2
The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection	2
Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications	2
The association of oxygen saturation, tomography findings and d-dimer levels in coronavirus disease 2019 patients	2
Thrombohaemorhhagic balance in coronavirus disease 2019 and its management: a perspective	2
Transplacental hemophilia A and prophylactic treatment with intravenous immunoglobulin and recombinant factor VIIa in the newborn period: a case report	2
Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey	2
Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility	2
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review	2
Chronic pain in haemophilia: assessment and analgesic treatment	2
Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications	2
Which tests can most effectively indicate the clinical phenotype of paediatric haemophilia patients with prophylaxis?	2
Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma	2
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience	2
Refractory acquired haemophilia A in a patient with HIV treated with Emicizumab	2
Expression and methylation status of vascular endothelial growth factor and thrombospondin-1 genes in congenital factor XIII-deficient patients with intracranial hemorrhage	2
Lidocaine effects on coagulation assessed by whole blood rotational thromboelastometry	2
Identification of two novel mutations in three children with congenital factor VII deficiency	2
Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency	2
Readability and quality assessment of internet-based patient education materials related to deep vein thrombosis	2
Protein S Erlangen: a novel PROS1 gene mutation associated with quantitative protein S deficiency	2
Hemostatic cover in orthopedic surgery	2
Fibrinolytic drugs induced hemorrhage: mechanisms and solutions	2
Factors associated with bleeding after ultrasound-assisted catheter-directed thrombolysis for the treatment of pulmonary embolism	2
Leukocyte-platelet rich fibrin on the treatment of a large paradental cyst: a novel regenerative approach	2
Coagulopathy following Crotaliπae snakebites in northeast Florida	2
Whole blood viscosity in patients with aortic stenosis	2
Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins	2
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays	2
The impact of neutrophil extracellular traps in coronavirus disease - 2019 pathophysiology	1
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus	1
Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran	1
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism	1
Reversal of life-threatening bleeding with protamine sulfate in a patient with plasma cell leukemia	1
The effects of lung involvement, clinical and laboratory parameters on outcome in elderly patients with coronavirus disease 2019	1
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage	1
Viscoelastic testing to assess the effects of rapid fibrinogen concentrate administration after cardiopulmonary bypass: insights from the REPLACE study	1
Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study	1
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients	1
Inferior Vena Cava agenesis presenting as deep vein thrombosis in an eight year-old girl	1
New treatments for primary immune thrombocytopenia	1
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT	1
The utility and complications of plasma administration in cirrhotic patients undergoing minimally invasive procedures	1
Hereditary coagulation factor XI deficiency: a rare or neglected disease? Results from a retrospective, single-centre cohort in northern Italy	1
Management of autoimmune factor XIII deficiency in a frail, elderly patient	1
Challenging treatment for refractory acquired haemophilia A complicated with severe severe acute respiratory coronavirus 2 infection	1
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe	1
A novel mutation (Ser951LeufsTer8) in F5 gene leads to hereditary coagulation factor V deficiency	1
Hemophilia carriers and women with coagulopathies: challenges in the occupational arena	1

Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism	1
Physician practices in evaluation and treatment of patients with generalized joint hypermobility and bleeding	1
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics	1
Clinical phenotype and F7 gene genotype in 40 Tunisian patients with congenital factor VII deficiency	1
Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients	1
Uvaol alleviates oxidative stress induced human umbilical vein endothelial cell injury by suppressing mitogen-activated protein kinase signaling pathway	1
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury	1
Hemophilia in the south of Tunisia	1
Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography	1
Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding	1
Hereditary factor V deficiency from heterozygous mutations with a novel variant p.Pro798Leufs∗13 in the F5 gene	1
Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia	1
Rotational thromboelastometry for diagnosis of fibrinolysis induced by urokinase in an in-vitro model	1
Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation	1
Preservation of thrombin generation in cirrhosis despite abnormal results of international normalized ratio: implications for invasive procedures	1
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study	1
Identification of a novel mutation in congenital afibrinogenemia in Iranian patients	1
Peripartum management of deep venous thrombosis in the context of antithrombin deficiency and May–Thurner syndrome	1
P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia	1
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice	1
Fibrin clot susceptibility to lysis is impaired after on-pump coronary artery by-pass grafting with tranexamic acid: clinical implications	1
2B or not 2B? A diagnosis of von Willebrand disease a lifetime of 86 years in the making	1
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease	1
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants	1
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab	1
Evaluation of primary care physicians’ approaches to hemophilia and bleeding disorders: a questionnaire survey	1
Evaluation of acquired and hereditary risk factors for the development of thromboembolism in patients with systemic lupus erythematosus	1
The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A	1
The most common disease-causing mutation of factor XIII deficiency is corrected by CRISPR/CAS9 gene editing system	1
Thromboelastometry-guided neuraxial anesthesia in a parturient with severe thrombocytopenia due to large granular lymphocytic leukemia	1
Clot waveform analysis in acute promyelocytic leukemia	1
Assessment of fibrinolytic markers in patients with deep vein thrombosis	1
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen	1
A novel mutation (Leu60Pro) in a Chinese pedigree with hereditary factor XI deficiency	1
Obesity and physical exercise in hemophilia	1
Isovolemic filter-based therapeutic plasma-exchange with fresh frozen plasma is associated with minimal thromboelastometric changes in noncoagulopathic patients	1
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing	1
Evaluation of the algorithm of Anticlot Assistant: an anticoagulant management system based on mobile health technology	1
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada	1
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study	1
Characterization of zebrafish gp1ba mutant and modelling Bernard Soulier syndrome	1
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding	1
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations	1
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study	1
Once-weekly prophylaxis regimen of nonacog alfa in patients with hemophilia B: an analysis of timing of bleeding event onset	1
State of the art of genetic studies in hemophilia carriers	1
Attention to diseases that re-emerge due to refusal of vitamin K: an infant case	1